Literature DB >> 1866378

Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water.

R M Evans1, S J Farr, N A Armstrong, S M Chatham.   

Abstract

Reverse micellization of nonionic surfactants in apolar media was applied to the formation of solution phase, pressurized inhalation aerosols, employing soya lecithin (SPC) and water in chlorofluorocarbon (CFC) blends. The use of a 30/70 mixture of trichlorofluoromethane (P11) and dichlorodifluoromethane (P12) resulted in the formation of stable, isotropic systems containing 0.5-2.0% (w/v) SPC and solubilized water; R (moles water/moles SPC), 0.9 to 4.28. In systems containing less than 30% P11, phase separation became apparent, particularly at higher water and surfactant concentrations. Dramatic changes in solution viscosity were noted on increasing R values and were attributed to an increase in asymmetry of SPC micelles. Dynamic fractionation of the output from pressurized aerosols using a four-stage liquid impinger showed that the respirable fraction (as measured by the percentage of emitted droplets with aerodynamic diameters less than 5.5 microns) was highly dependent on SPC concentration and R. A significant correlation between RF and actuator score, based on orifice diameter and length, was also found and confirmed that the highest RF values were achieved with the systems of lowest SPC and water concentrations sprayed through an actuator with the smallest and shortest orifice dimensions. This novel mechanism for the formulation of hydrophilic drugs as solutions within CFC-based pressurized aerosols may offer advantages over the traditional suspension approach to pulmonary drug delivery.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866378     DOI: 10.1023/a:1015813009024

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Delivery of propellant soluble drug from a metered dose inhaler.

Authors:  H L Ashworth; C G Wilson; E E Sims; P K Wotton; J G Hardy
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

2.  Optimized inhalation aerosols. I. The effects of spherical baffle size and position upon the output of several pressurized nonaqueous suspension formulations.

Authors:  P R Byron; R N Dalby; A J Hickey
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

3.  Influence of formulation on aerosol particle size.

Authors:  G P Polli; W M Grim; F A Bacher; M H Yunker
Journal:  J Pharm Sci       Date:  1969-04       Impact factor: 3.534

4.  Variation in delivery of isoprenaline from various pressurized inhalers.

Authors:  J H Bell; K Brown; J Glasby
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

5.  Pressurised aerosol deposition in the human lung with and without an "open" spacer device.

Authors:  S P Newman; A R Clark; N Talaee; S W Clarke
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

6.  Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions.

Authors:  R N Dalby; P R Byron
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

7.  The effect of solubilized water on the size and shape of lecithin micelles in an apolar solvent.

Authors:  R M Evans; D Attwood; S M Chatham; S J Farr
Journal:  J Pharm Pharmacol       Date:  1990-09       Impact factor: 3.765

8.  Spectroscopic investigations of the water pool in lecithin reverse micelles.

Authors:  V V Kumar; P Raghunathan
Journal:  Lipids       Date:  1986-12       Impact factor: 1.880

9.  The solubilization of progesterone by mixed bile salt-phospholipid sols.

Authors:  G P Martin; I W Kellaway; C Marriott
Journal:  Chem Phys Lipids       Date:  1978-10       Impact factor: 3.329

  9 in total
  3 in total

1.  Systemic delivery of cetrorelix to rats by a new aerosol delivery system.

Authors:  R Lizio; T Klenner; A W Sarlikiotis; P Romeis; D Marx; T Nolte; W Jahn; G Borchard; C M Lehr
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

2.  Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a.

Authors:  R O Williams; J Liu; J J Koleng
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

3.  Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.

Authors:  Mark L Sommerville; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2003-11-26       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.